Scrip Awards 2018
The 14th Annual Scrip Awards
28 November 2018
The Scrip Awards took place 28 November at the Hilton on Park Lane, London. View the full list of winners here
Rt Hon Lord William Hague will presided over the evening which saw full range of industry activities from big pharma, biotech companies and CROs is represented. From novel deals, to new drug launches and finding technological breakthroughs in clinical trials, the Scrip Awards provide the industry with an opportunity to acknowledge its highest achievers across all parts of the value chain and to recognize both corporate and individual achievement.
IQVIA™ is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward.
IQVIA enables companies to rethink approaches to clinical development and commercialization, innovate with confidence as well as accelerate meaningful healthcare outcomes. IQVIA has approximately 55,000 employees in more than 100 countries, all committed to making the potential of Human Data Science a reality. IQVIA’s approach to Human Data Science is powered by the IQVIA CORE™, driving unique actionable insights at the intersection of big data, advanced technology and analytics with extensive industry knowledge. To learn more, visit www.iqvia.com.
Medidata is leading the digital transformation of life sciences, with the world's most used platform for clinical development, commercial, and real-world data. Powered by artificial intelligence and delivered by the #1 ranked industry experts, the Intelligent Platform for Life Sciences helps pharmaceutical, biotech, medical device companies, and academic researchers accelerate value, minimize risk and optimize outcomes. Medidata serves more than 1,000 customers and partners worldwide and empowers more than 100,000 certified users every day to create hope for millions of patients. Discover the future of life sciences: www.mdsol.com
MC Services AG (Munich, Düsseldorf, London and Boston, USA), is the international corporate communications and investor relations firm for the life sciences and healthcare industries. A strong team of science, finance, media and communication experts with extensive industry experience, positions MC Services as a leading European life sciences agency. Our long-standing clients include international public and private companies, as well as venture capitalists and investment firms. Established since 2000, as a connection between the healthcare industry and the financial markets, MC Services is known for strategic advice and services in investor relations, public relations and financial transactions.
MSD has a strong history of success in translating cutting-edge research into life-saving medical breakthroughs. Our European Innovation Hub (located in London) is embedded in one of Europe’s key scientific communities to drive engagement with local academia, biotech, peer pharma and venture capitalists. The Hub includes a Business Development & Licensing team, Clinical teams and our UK Discovery Research Centre. The Centre, established in 2018, will drive scientific and medical advances against some of the most challenging diseases facing ageing populations. It will initially focus on the study of changes in the fundamental mechanisms of cell homeostasis and resilience in the context of ageing that lead to disease.
Globally, with more than 100 significant business development transactions since 2017, our team has experience working on collaborations from discovery through clinical-stage programs. We believe that by working together we can play a major role in transforming global health care. Together we can invent for life. Learn more at msd.com/licensing
Founded in 1978, Lachman Consultants provides expert compliance, regulatory affairs, and technical services to clients around the world. Lachman helps organizations to prevent and resolve compliance problems and to develop efficient and effective strategies for the submission and approval of drugs and devices. The company deploys only highly experienced consultants who consistently deliver top quality results for a diverse base of global clients—including pharmaceutical, biotechnology, medical device, and dietary supplement companies and the law firms that serve them.
Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry-leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Skipta is the leading social network of specialized online medical communities for verified healthcare professionals (HCPs). Skipta’s growing network of more than 30 specialty communities allow verified HCPs to communicate and collaborate with peers in a focused, secure environment. The company enables pharmaceutical and biotech brands to drive awareness and behavior change by bringing to them multi-channel access to 800,000+ verified HCPs through integrated engagement programs.
One of the world’s leading, full-service contract research organizations (CROs), Worldwide Clinical Trials employs more than 1,400 professionals around the world. Grounded in medicine and science, we strive to help patients live longer, better lives by partnering with pharmaceutical and biotechnology companies to bring new drug and device discoveries to market. Our employees are among the best in their fields – medical, scientific, and research professionals – who are committed to the well-being of all our clinical trial participants.
WuXi AppTec Group is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform, with global operations. As an innovation-driven and customer-focused platform, WuXi AppTec Group provides a broad and integrated portfolio of services to help our worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D, through cost-effective and efficient solutions. With its industry-leading capabilities such as small molecule R&D and manufacturing, cell and gene therapy R&D and manufacturing, medical device testing, biologics R&D and manufacturing, genomics and molecular diagnostics, WuXi’s platform is enabling more than 3,000 innovative collaborators from more than 30 countries to bring innovative healthcare products to patients, and to fulfill WuXi's dream that "every drug can be made and every disease can be treated.